Immuron IMRN
NASDAQ IMRN
$1.12 -0.06 (-5.08%)
As of: Aug 21, 2026 · 3:58 PM EDT

Immuron (IMRN) Depreciation & Amortization (CF) (2020 - 2023)

Immuron (IMRN) posted quarterly Depreciation & Amortization (CF) of $32523.8 for Q2 2023, up 70.62% year-over-year from $19062.0 in Q2 2022, and up 70.62% quarter-over-quarter from $19062.0 in Q2 2022.

Immuron (IMRN) Depreciation & Amortization (CF) (2020 - 2023) Analysis & Trends

Immuron's Depreciation & Amortization (CF) history runs 4 years deep, the most recent figure standing at $32523.8 for Q2 2023.

  • In Q2 2023, Depreciation & Amortization (CF) rose 70.62% year-over-year to $32523.8; the TTM figure through Dec 2023 stood at $32523.8 (up 70.62% YoY), while the FY2023 annual figure was $32523.8, up 70.62% from the prior year.
  • Depreciation & Amortization (CF) for Q2 2023 stood at $32523.8, up from $19062.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $33622.1 in Q2 2021, with the low at $19062.0 in Q2 2022.
  • The 4-year median for Depreciation & Amortization (CF) is $30699.5 (2023), against an average of $28520.8.
  • The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) tumbled 43.31% in 2022, then surged 70.62% in 2023.
  • Immuron's Depreciation & Amortization (CF) stood at $28875.2 in 2020, then increased by 16.44% to $33622.1 in 2021, then sank by 43.31% to $19062.0 in 2022, then soared by 70.62% to $32523.8 in 2023.
  • Business Quant data shows IMRN's Depreciation & Amortization (CF) at $32523.8 in Q2 2023, $19062.0 in Q2 2022, and $33622.1 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 40.52 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 191.83 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Immuron 6.75 Mn 6.73 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 32,523.76
Jun 30, 2023 32,523.76
Jun 30, 2022 19,062.05
Jun 30, 2022 19,062.05
Jun 30, 2021 33,622.15
Jun 30, 2021 33,622.15
Jun 30, 2020 28,875.21
Jun 30, 2020 28,875.21